May 4, 2017 in Biotech Industry News RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study, Colon Cancer News Today Kineta Inc 1 Like Post Comments Off on RLR Agonists Seen to Promote Immune Response Against Colon Cancer Cells in Early Study, Colon Cancer News Today Read More
March 4, 2017 in Biotech Industry News A little mollusk may lead to a big discovery in helping solve the U.S. opioid epidemic Kineta Inc 1 Like Post Comments Off on A little mollusk may lead to a big discovery in helping solve the U.S. opioid epidemic Read More
February 22, 2017 in Biotech Industry News Biotech startup tries unique weapon in fight against chronic pain and opioid addiction: snail venom Kineta Inc 1 Like Post Comments Off on Biotech startup tries unique weapon in fight against chronic pain and opioid addiction: snail venom Read More
February 22, 2017 in Biotech Industry News Biggest Northwest angel group Keiretsu details its top Seattle-area investments Kineta Inc 1 Like Post Comments Off on Biggest Northwest angel group Keiretsu details its top Seattle-area investments Read More
February 21, 2017 in Biotech Industry News Snail venom compound ‘offers chronic pain therapy Kineta Inc 2 Like Post Comments Off on Snail venom compound ‘offers chronic pain therapy Read More
August 5, 2016 in Biotech Industry News As millions visit Rio Olympics, a lack of funding leaves Zika researchers in the dark, GeekWire Kineta Inc 2 Like Post Comments Off on As millions visit Rio Olympics, a lack of funding leaves Zika researchers in the dark, GeekWire Read More
May 11, 2016 in Biotech Industry News Kineta wins $7.2M award to develop antiviral drug focused on Lassa fever, GeekWire Kineta Inc 2 Like Post Comments Off on Kineta wins $7.2M award to develop antiviral drug focused on Lassa fever, GeekWire Read More
May 5, 2016 in Biotech Industry News Seattle biotech Kineta wins $7.2M award for drug development, Puget Sound Business Journal Kineta Inc 2 Like Post Comments Off on Seattle biotech Kineta wins $7.2M award for drug development, Puget Sound Business Journal Read More
